KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Assets Average (2016 - 2025)

Historic Assets Average for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $113.7 billion.

  • Eli Lilly's Assets Average rose 4736.17% to $113.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $113.7 billion, marking a year-over-year increase of 4736.17%. This contributed to the annual value of $95.6 billion for FY2025, which is 3396.11% up from last year.
  • According to the latest figures from Q4 2025, Eli Lilly's Assets Average is $113.7 billion, which was up 4736.17% from $107.9 billion recorded in Q3 2025.
  • In the past 5 years, Eli Lilly's Assets Average registered a high of $113.7 billion during Q4 2025, and its lowest value of $46.7 billion during Q1 2021.
  • Over the past 5 years, Eli Lilly's median Assets Average value was $55.2 billion (recorded in 2023), while the average stood at $64.4 billion.
  • Its Assets Average has fluctuated over the past 5 years, first plummeted by 153.23% in 2022, then surged by 4736.17% in 2025.
  • Quarter analysis of 5 years shows Eli Lilly's Assets Average stood at $48.5 billion in 2021, then decreased by 0.04% to $48.5 billion in 2022, then rose by 25.76% to $61.0 billion in 2023, then increased by 26.57% to $77.2 billion in 2024, then soared by 47.36% to $113.7 billion in 2025.
  • Its Assets Average stands at $113.7 billion for Q4 2025, versus $107.9 billion for Q3 2025 and $95.2 billion for Q2 2025.